A Pilot Study to Test Whether Systemic Interferon Gamma Increases Tumor Class I MHC Expression in Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Liposarcoma; Synovial sarcoma
- Focus Biomarker; Pharmacodynamics
- 02 Oct 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2018.
- 10 Jun 2017 Biomarkers information updated
- 12 Apr 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.